ATE414540T1 - Impfstoffe gegen allergien - Google Patents

Impfstoffe gegen allergien

Info

Publication number
ATE414540T1
ATE414540T1 AT03740967T AT03740967T ATE414540T1 AT E414540 T1 ATE414540 T1 AT E414540T1 AT 03740967 T AT03740967 T AT 03740967T AT 03740967 T AT03740967 T AT 03740967T AT E414540 T1 ATE414540 T1 AT E414540T1
Authority
AT
Austria
Prior art keywords
vaccines against
against allergies
polypeptides
allergies
adjuvants
Prior art date
Application number
AT03740967T
Other languages
English (en)
Inventor
Lars Hellman
Stephen Persson
Asa Jansson
Original Assignee
Resistentia Pharmaceuticals Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Resistentia Pharmaceuticals Ab filed Critical Resistentia Pharmaceuticals Ab
Application granted granted Critical
Publication of ATE414540T1 publication Critical patent/ATE414540T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39566Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against immunoglobulins, e.g. anti-idiotypic antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52Constant or Fc region; Isotype

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
AT03740967T 2002-09-05 2003-06-02 Impfstoffe gegen allergien ATE414540T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40864802P 2002-09-05 2002-09-05

Publications (1)

Publication Number Publication Date
ATE414540T1 true ATE414540T1 (de) 2008-12-15

Family

ID=31978650

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03740967T ATE414540T1 (de) 2002-09-05 2003-06-02 Impfstoffe gegen allergien

Country Status (9)

Country Link
US (2) US20040054146A1 (de)
EP (1) EP1545607B1 (de)
JP (1) JP2006510588A (de)
AT (1) ATE414540T1 (de)
AU (1) AU2003297953B2 (de)
CA (1) CA2497660A1 (de)
DE (1) DE60324816D1 (de)
ES (1) ES2316780T3 (de)
WO (1) WO2004022094A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080118524A1 (en) * 2006-10-20 2008-05-22 Stefan Persson Anti-IgE Vaccines
JP2011001273A (ja) * 2009-06-16 2011-01-06 Eci Inc eMIPを有効成分とする水溶性製剤
GB2500204A (en) * 2012-03-13 2013-09-18 Intercell Ag Vaccine comprising aluminium adjuvant having low levels of contaminating heavy metal ions
US9895437B2 (en) 2012-04-18 2018-02-20 Valneva Austria Gmbh Aluminum compounds for use in therapeutics and vaccines

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3876763A (en) * 1970-12-29 1975-04-08 Shionogi & Co Infectious coryza infectious bronchitis and newcastle disease vaccines and production thereof
US4873191A (en) * 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
JPH03503403A (ja) * 1987-07-06 1991-08-01 ペプチド テクノロジー リミテッド 生物学的に活性な分子
US5703055A (en) * 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
SE9102808L (sv) * 1991-09-26 1993-03-27 Lars T Hellman Inst F Immunolo Vaccin, foer humant bruk, vars avsedda effekt aer att lindra symptomen eller foerhindra uppkomsten av ige-medierade allergiska reaktioner
US6913749B2 (en) * 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
EP1967205B1 (de) * 2000-08-30 2012-10-10 Pfizer Products Inc. Anti-IgE Vakzine
WO2003096966A2 (en) * 2002-05-21 2003-11-27 Resistentia Pharmaceuticals Ab Chimeric ige polypeptides and host cells

Also Published As

Publication number Publication date
EP1545607A1 (de) 2005-06-29
ES2316780T3 (es) 2009-04-16
AU2003297953B2 (en) 2009-02-26
CA2497660A1 (en) 2004-03-18
US20040054146A1 (en) 2004-03-18
WO2004022094A1 (en) 2004-03-18
US20090191268A1 (en) 2009-07-30
DE60324816D1 (de) 2009-01-02
JP2006510588A (ja) 2006-03-30
AU2003297953A1 (en) 2004-03-29
EP1545607B1 (de) 2008-11-19

Similar Documents

Publication Publication Date Title
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
DK1877390T3 (da) Benzisoxazol-piperazin-forbindelser og fremgangsmåder til anvendelse deraf
TW200732349A (en) Anti-OX40L antibodies and methods using same
TW200745161A (en) Stable antibody formulation
NO20071740L (no) Humaniserte anti-beta7-antagonister og anvendelser derav
ATE507822T1 (de) Stabilisierte zusammensetzungen von faktor-vii- polypeptiden
IL214325A (en) Antibody against cmet, a drug that includes and uses it
MX2009013199A (es) Anticuerpos anti-notch1 nnr y sus metodos de uso.
SG158141A1 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
SE0301653D0 (sv) Novel compounds
NO20083397L (no) Anti-EphB4-antistoffer og fremgangsmater for anvendelse av disse
NO20052149D0 (no) Vaksine.
RS51694B (en) NEW PERINDOPRIL AND PHARMACEUTICAL COMPOSITIONS CONTAINING THERE
WO2003103571A3 (en) VACCINES AGAINST FLAVIVIRUSES
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
NO20083593L (no) Anti-EphrinB2-antistoffer og fremgangsmater for anvendelse av disse
ATE551069T1 (de) Mucin-fusionspolypeptid-vakzine, zusammensetzungen und ihre verwendung
EA200601596A1 (ru) Улучшенный состав 6-меркаптопурина
IL173929A0 (en) Analogues of kahalalide f and pharmaceutical compositions containing the same
SE0301650D0 (sv) Novel compounds
MX2007007355A (es) 5-(2,2-dimetil-ciclopropil)-3-metil-pen-2-en nitrilo como fragancia y sabor.
DE60324816D1 (de) Impfstoffe gegen allergien
DE60326773D1 (de) Peptid-deformylase-hemmer
ATE391489T1 (de) Haarbehandlungszusammensetzungen
DE60207833D1 (de) Peptiddeformylase-hemmer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties